UiPath Inc. (NYSE:PATH) Receives Average Rating of “Moderate Buy” from Analysts

Shares of UiPath Inc. (NYSE:PATH) have been given a consensus rating of “Moderate Buy” by the eighteen research firms that are covering the stock, Marketbeat reports. Nine equities research analysts have rated the stock with a hold rating and nine have issued a buy rating on the company. The average 12-month target price among brokers that have updated their coverage on the stock in the last year is $27.41.

A number of brokerages have commented on PATH. Truist Financial restated a “buy” rating and set a $32.00 price objective on shares of UiPath in a research report on Wednesday, March 20th. BMO Capital Markets increased their price target on shares of UiPath from $24.00 to $28.00 and gave the company a “market perform” rating in a report on Thursday, March 14th. Mizuho increased their price target on shares of UiPath from $22.00 to $25.00 and gave the company a “neutral” rating in a report on Thursday, March 14th. TD Cowen increased their price objective on shares of UiPath from $25.00 to $28.00 and gave the company an “outperform” rating in a research note on Thursday, March 14th. Finally, Royal Bank of Canada reaffirmed a “sector perform” rating and set a $29.00 price target on shares of UiPath in a research note on Monday, April 1st.

Insider Buying and Selling at UiPath

In other UiPath news, CFO Ashim Gupta sold 40,000 shares of the company’s stock in a transaction dated Thursday, April 4th. The stock was sold at an average price of $21.66, for a total value of $866,400.00. Following the completion of the transaction, the chief financial officer now owns 660,762 shares of the company’s stock, valued at approximately $14,312,104.92. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Insiders sold a total of 72,000 shares of company stock worth $1,591,360 over the last ninety days. 31.03% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in PATH. Mark Sheptoff Financial Planning LLC purchased a new stake in UiPath in the fourth quarter worth $25,000. HighMark Wealth Management LLC bought a new stake in shares of UiPath in the 4th quarter valued at about $27,000. Tyler Stone Wealth Management bought a new stake in shares of UiPath in the 2nd quarter valued at about $28,000. Cypress Capital Management LLC WY purchased a new position in UiPath during the 4th quarter valued at about $29,000. Finally, Fifth Third Bancorp increased its holdings in UiPath by 2,005.3% during the 3rd quarter. Fifth Third Bancorp now owns 2,000 shares of the healthcare company’s stock valued at $34,000 after purchasing an additional 1,905 shares during the period. Institutional investors own 62.50% of the company’s stock.

UiPath Stock Performance

Shares of UiPath stock opened at $19.49 on Tuesday. UiPath has a one year low of $12.38 and a one year high of $27.87. The firm has a fifty day moving average of $23.24 and a two-hundred day moving average of $21.46.

UiPath (NYSE:PATH) last announced its quarterly earnings data on Wednesday, March 13th. The healthcare company reported $0.06 EPS for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.10. The company had revenue of $405.25 million during the quarter, compared to the consensus estimate of $383.32 million. UiPath had a negative net margin of 6.87% and a negative return on equity of 3.29%. On average, equities research analysts forecast that UiPath will post -0.04 earnings per share for the current fiscal year.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.